<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-04T20:30:14+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>武田制药荣获天津市先进外商投资企业称号</title>
    <updated>2020-12-04T17:56:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/oXUGvkjc0UCiFVhooT3upA</id>
    <link href="https://mp.weixin.qq.com/s/oXUGvkjc0UCiFVhooT3upA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 来自邱录贵教授团队——多发性骨髓瘤中国研究专题</title>
    <updated>2020-12-04T17:56:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/yzl-Vg8HYt0qQtJnfV7MXA</id>
    <link href="https://mp.weixin.qq.com/s/yzl-Vg8HYt0qQtJnfV7MXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访 | 陈锐教授：FVIII药代动力学计算工具助力血友病个体化治疗</title>
    <updated>2020-12-03T18:12:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/9-WgGGHKO19l2hVxVRkKWQ</id>
    <link href="https://mp.weixin.qq.com/s/9-WgGGHKO19l2hVxVRkKWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>J-ALTA二期临床结果（阿来替尼→布格替尼）</title>
    <updated>2020-12-02T20:52:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/ES4sDlFKF-XVPDG1JYUTCQ</id>
    <link href="https://mp.weixin.qq.com/s/ES4sDlFKF-XVPDG1JYUTCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>口服剂型:Relugolix用于晚期前列腺癌的雄激素剥夺治疗</title>
    <updated>2020-12-01T19:10:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/q-60I8Ne49VZ9sa0QAiy2Q</id>
    <link href="https://mp.weixin.qq.com/s/q-60I8Ne49VZ9sa0QAiy2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访 | 蔡真教授：多发性骨髓瘤患者的维持治疗</title>
    <updated>2020-12-01T19:10:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/3X-sT7fPp2FU_XSgTTLw0Q</id>
    <link href="https://mp.weixin.qq.com/s/3X-sT7fPp2FU_XSgTTLw0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>纳武利尤单抗联合化放疗治疗不可手术的III期NSCLC</title>
    <updated>2020-11-30T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/K2pfUn8xkpH1N-RoNV601w</id>
    <link href="https://mp.weixin.qq.com/s/K2pfUn8xkpH1N-RoNV601w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD30学院 | 李剑教授——抗体偶联药物（ADC）概述</title>
    <updated>2020-11-30T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/zZoh0cp4FApLUEVFVYZBEg</id>
    <link href="https://mp.weixin.qq.com/s/zZoh0cp4FApLUEVFVYZBEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访 | 傅卫军教授：中国MM诊治现状，规范化诊疗是关键！</title>
    <updated>2020-11-30T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/Rk5MCySE0SPiw4xl3z880g</id>
    <link href="https://mp.weixin.qq.com/s/Rk5MCySE0SPiw4xl3z880g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>洛拉替尼Lorlatinib的ALK耐药机制更新</title>
    <updated>2020-11-30T18:06:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/bN6EwbujLdFEE3iUsvmXdg</id>
    <link href="https://mp.weixin.qq.com/s/bN6EwbujLdFEE3iUsvmXdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一代传奇球王:马拉多纳</title>
    <updated>2020-11-28T10:12:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/DqEttG42vW9sPW09fMPCtA</id>
    <link href="https://mp.weixin.qq.com/s/DqEttG42vW9sPW09fMPCtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访 | 李军民教授：精确分层评估系统，助力老年多发性骨髓瘤患者精准治疗</title>
    <updated>2020-11-27T22:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/52DbfEjS3oFUTexU9A7SRQ</id>
    <link href="https://mp.weixin.qq.com/s/52DbfEjS3oFUTexU9A7SRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 复发难治性多发性骨髓瘤最新研究汇总</title>
    <updated>2020-11-27T22:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/AXSGQWgiuQTrnYrH5e98uQ</id>
    <link href="https://mp.weixin.qq.com/s/AXSGQWgiuQTrnYrH5e98uQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 维布妥昔单抗在霍奇金淋巴瘤中最新研究详述</title>
    <updated>2020-11-26T21:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/MqU3uDzcmjdRPOb2MvLcug</id>
    <link href="https://mp.weixin.qq.com/s/MqU3uDzcmjdRPOb2MvLcug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 新诊断多发性骨髓瘤的前沿进展</title>
    <updated>2020-11-26T21:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/UuI9749yJErljSIiU91yqg</id>
    <link href="https://mp.weixin.qq.com/s/UuI9749yJErljSIiU91yqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>对既往应用百因止治疗的血友病A患者的抑制物产生、安全性和有效性在日本的一项上市后监测</title>
    <updated>2020-11-26T21:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/CjVSlAoAQv71ahFXEIJUlw</id>
    <link href="https://mp.weixin.qq.com/s/CjVSlAoAQv71ahFXEIJUlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>唯一肠道选择性生物制剂安吉优®中国上市</title>
    <updated>2020-11-22T14:27:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/Xq4mJuNaiC04Gmwa1wmD5g</id>
    <link href="https://mp.weixin.qq.com/s/Xq4mJuNaiC04Gmwa1wmD5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访 | 钟玉萍教授：助力骨髓瘤持续治疗，口服PI与激素二药方案维持</title>
    <updated>2020-11-22T14:27:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/XZJngmCNDqcPJVtg9V6SKg</id>
    <link href="https://mp.weixin.qq.com/s/XZJngmCNDqcPJVtg9V6SKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 外周T细胞淋巴瘤和B细胞淋巴瘤最新研究汇总</title>
    <updated>2020-11-22T14:27:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/kSvazlJAX6UfjAs32eBcug</id>
    <link href="https://mp.weixin.qq.com/s/kSvazlJAX6UfjAs32eBcug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020ASH好声音 | 口服蛋白酶体抑制剂血液肿瘤领域最新研究汇总</title>
    <updated>2020-11-20T08:28:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/jB8Q0HCn2JcExTgOKj__Gw</id>
    <link href="https://mp.weixin.qq.com/s/jB8Q0HCn2JcExTgOKj__Gw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>